VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
UNH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
UNHUnitedHealth Group Incorporated
$389.68$353.9B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUNHFinancials

UnitedHealth Group Incorporated (UNH) Income Statement

30Y historyFree accessUpdated daily

Revenue has stayed near $112B per quarter while the loss ratio swung between 67.3% and 83.7% over the period, suggesting that medical cost trends rather than top-line expansion are driving the earnings profile.

Income StatementBalance SheetCash FlowRatios

UNH Income Statement

Annual statement

UNH Income Statement

UnitedHealth Group Incorporated (UNH) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue449.66B447.57B400.28B371.62B324.16B287.6B257.14B242.16B226.25B201.16B184.84B157.11B130.47B122.49B110.62B101.86B94.16B87.14B81.19B75.43B71.54B46.43B37.22B28.57B25.02B23.45B21.12B19.56B17.36B11.79B10.07B
Revenue Growth %3.33%11.81%7.71%14.64%12.71%11.84%6.19%7.03%12.47%8.83%17.65%20.41%6.52%10.73%8.6%8.19%8.05%7.33%7.63%5.44%54.08%24.76%30.29%14.17%6.68%11.04%7.97%12.72%47.15%17.08%77.64%
Medical Costs & Claims347.08B364.65B310.88B280.66B244.54B217.94B190.14B184.56B172.4B154.15B141.45B120.08B97.04B92.13B82.75B92.27B85.23B79.79B61.84B56.2B53.91B32.73B27B20.71B18.19B21.62B16.16B15.04B13.52B8.54B7.18B
Medical Cost Ratio %77.19%81.47%77.67%75.52%75.44%75.78%73.94%76.21%76.2%76.63%76.53%76.43%74.38%75.21%74.81%90.59%90.52%91.57%76.17%74.51%75.35%70.48%72.55%72.51%72.71%92.19%76.48%76.9%77.92%72.43%71.27%
Gross Profit102.58B82.92B89.4B90.96B79.62B69.65B67B57.6B53.85B47.01B43.39B37.03B33.43B30.36B27.87B9.59B8.93B7.35B19.35B19.23B16.76B12.14B-28.64B7.85B6.83B1.83B4.97B4.52B3.83B3.25B2.89B
Gross Margin %22.81%18.53%22.33%24.48%24.56%24.22%26.06%23.79%23.8%23.37%23.47%23.57%25.62%24.79%25.19%9.41%9.48%8.43%23.83%25.49%23.43%26.15%-76.96%27.49%27.29%7.81%23.52%23.1%22.08%27.57%28.73%
Gross Profit Growth %--7.25%-1.71%14.24%14.31%3.96%16.32%6.97%14.54%8.36%17.18%10.75%10.12%8.94%190.67%7.39%21.47%-62.01%0.62%14.7%38.08%142.39%-464.77%15%272.91%-63.14%9.91%17.93%17.84%12.37%66.33%
Operating Expenses78.66B63.95B57.11B58.6B51.18B45.68B44.59B37.91B36.5B31.8B30.46B26B23.16B20.74B18.61B1.12B1.06B991M14.08B11.38B10.65B7.27B-32.74B5.17B4.64B265M3.77B3.58B3.87B2.51B2.3B
OpEx / Revenue %17.49%14.29%14.27%15.77%15.79%15.88%17.34%15.66%16.13%15.81%16.48%16.55%17.75%16.93%16.83%1.1%1.13%1.14%17.35%15.09%14.89%15.65%-87.98%18.11%18.55%1.13%17.83%18.28%22.32%21.28%22.81%
Depreciation & Amortization4.26B4.36B4.1B3.97B3.4B3.1B2.89B2.72B2.43B2.25B2.06B1.69B1.48B1.38B1.31B1.12B1.06B991M981M796M670M453M374M299M255M265M247M233M185M146M133.17M
Combined Ratio %94.68%95.76%91.93%91.29%91.23%91.67%91.29%91.87%92.33%92.44%93%92.99%92.13%92.14%91.63%91.69%91.65%92.7%93.52%89.59%90.24%86.13%-15.43%90.63%91.26%93.32%94.32%95.18%100.24%93.71%94.08%
Operating Income23.92B18.96B32.29B32.36B28.43B23.97B22.41B19.68B17.34B15.21B12.93B11.02B10.27B9.62B9.25B8.46B7.86B6.36B5.26B7.85B6.98B5.08B4.1B2.67B2.19B1.57B1.2B943M-42M742M596.41M
Operating Margin %5.32%4.24%8.07%8.71%8.77%8.33%8.71%8.13%7.67%7.56%7%7.01%7.87%7.86%8.37%8.31%8.35%7.3%6.48%10.41%9.76%10.94%11.02%9.35%8.74%6.68%5.68%4.82%-0.24%6.29%5.92%
Operating Income Growth %--41.26%-0.22%13.8%18.63%6.98%13.82%13.5%14.04%17.63%17.32%7.27%6.77%3.99%9.33%7.63%23.67%20.82%-32.95%12.39%37.48%23.87%53.54%22.19%39.59%30.5%27.25%2345.24%-105.66%24.41%29.43%
EBITDA28.18B23.32B36.39B36.33B31.84B27.07B25.3B22.41B19.77B17.45B14.98B12.71B11.75B11B10.56B9.59B8.93B7.35B6.24B8.64B7.65B5.53B4.47B2.97B2.44B1.83B1.45B1.18B143M888M729.58M
EBITDA Margin %6.27%5.21%9.09%9.78%9.82%9.41%9.84%9.25%8.74%8.68%8.11%8.09%9.01%8.98%9.55%9.41%9.48%8.43%7.69%11.46%10.7%11.92%12.02%10.4%9.76%7.81%6.85%6.01%0.82%7.53%7.24%
Interest Expense3.85B4B3.91B3.25B2.09B1.66B1.66B1.7B1.4B1.19B1.07B790M618M708M632M505M481M551M639M544M456M241M128M95M90M94M00000
Non-Operating Income191M265M8.31B00000000000000000000-27.02B000-37.24B-725M0-14.97M
Pretax Income19.73B14.7B20.07B29.11B26.34B22.31B20.74B17.98B15.94B14.02B11.86B10.23B9.66B8.91B8.62B7.96B7.38B5.81B4.62B7.3B6.53B4.84B3.97B2.84B2.1B1.47B1.16B894M-46M742M580.85M
Pretax Margin %4.39%3.28%5.01%7.83%8.13%7.76%8.07%7.43%7.05%6.97%6.42%6.51%7.4%7.28%7.79%7.81%7.84%6.67%5.7%9.68%9.12%10.42%10.67%9.94%8.38%6.28%5.47%4.57%-0.27%6.29%5.77%
Income Tax3.07B1.89B4.83B5.97B5.7B4.58B4.97B3.74B3.56B3.2B4.79B4.36B4.04B3.24B3.1B2.82B2.75B1.99B1.65B2.65B2.37B1.76B1.39B1.01B744M559M419M326M120M282M224.6M
Effective Tax Rate %15.54%12.86%24.06%20.5%21.65%20.52%23.98%20.81%22.34%22.82%40.38%42.64%41.81%36.37%35.91%35.39%37.23%34.19%35.62%36.29%36.29%36.29%34.89%35.74%35.5%37.98%36.28%36.47%-260.87%38.01%38.67%
Net Income15.88B12.06B14.4B22.38B20.12B17.29B15.4B13.84B11.99B10.56B7.02B5.81B5.62B5.63B5.53B5.14B4.63B3.82B2.98B4.65B4.16B3.08B2.59B1.66B1.35B913M736M568M-166M460M355.64M
Net Margin %3.53%2.69%3.6%6.02%6.21%6.01%5.99%5.71%5.3%5.25%3.8%3.7%4.31%4.59%5%5.05%4.92%4.39%3.67%6.17%5.81%6.64%6.95%5.79%5.4%3.89%3.48%2.9%-0.96%3.9%3.53%
Net Income Growth %-9.69%-16.31%-35.64%11.24%16.4%12.22%11.3%15.46%13.53%50.46%20.71%3.45%-0.11%1.79%7.47%10.96%21.25%28.38%-36.03%11.9%34.9%19.17%56.31%22.41%48.08%24.05%29.58%442.17%-136.09%29.35%24.36%
EPS (Diluted)17.6113.2315.5123.8621.1818.0816.0314.3312.1910.727.256.015.705.505.284.734.103.242.403.422.972.311.831.341.070.700.550.40-0.140.280.22
EPS Growth %-8.55%-14.7%-35%12.65%17.15%12.79%11.86%17.56%13.71%47.86%20.63%5.44%3.64%4.17%11.63%15.37%26.54%35%-29.82%15.15%28.57%26.23%36.57%25.23%52.86%27.27%37.5%385.71%-150%27.27%10%
EPS (Basic)-13.2315.6424.1221.5418.3316.2814.5512.4510.957.376.105.785.595.384.814.143.272.453.553.092.441.931.401.120.730.570.41-0.140.290.22
Diluted Shares Outstanding902M910M929M938M950M956M961M966M983M985M968M967M986M1.02B1.05B1.09B1.13B1.18B1.24B1.36B1.4B1.33B1.32B1.24B1.27B1.3B1.35B1.42B1.52B1.53B1.49B

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Medicare Advantage utilization and DOJ scrutiny

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Medical Cost Pressure Dominates Underwriting Results

Based on reported figures, UNH's combined ratio moved from 91.7% in 2025Q1 to 99.7% in 2025Q4 before recovering to 94.2% in 2026Q3, indicating underwriting margins remain sensitive to medical cost swings across the period.

The loss ratio ranged from roughly 67% to 84% over the ten quarters shown, with the 2025 peak coinciding with elevated utilization among senior members. A combined ratio above 100% would mean underwriting losses that depend on investment income to produce profit, and the 2025Q4 print came close to that threshold. Investors should monitor whether the 2026 recovery reflects durable cost control or favorable timing in reserve estimates.

Revenue Growth Slows as Premium Base Matures

As reported in the quarterly financial statements, UNH's revenue growth decelerated from double-digit rates in 2025 to roughly flat in 2026Q3 at negative 0.4%, suggesting premium pricing and membership gains are no longer offsetting cost resets.

Revenue expansion through 2025 was strong, but the sequential stall in 2026 may indicate limits to premium repricing in Medicare Advantage and commercial books. Flat top-line growth paired with a rising EPS trajectory in the latest quarters points to margin-driven earnings rather than volume-driven expansion. Sustained revenue stagnation would challenge the thesis that Optum-driven service revenue can carry consolidated growth.

Quarterly EPS Swings Warrant Reserve Scrutiny

Based on UNH's reported figures, diluted EPS fell from $6.85 in 2025Q1 to $0.01 in 2025Q4 before rebounding to $6.90 in 2026Q1, a volatility pattern that may reflect prior-year reserve development rather than run-rate earnings.

Sharp quarterly earnings compression of this magnitude is often linked to reserve adjustments on medical claims incurred in earlier periods. The reported data do not isolate prior-year development, so the underlying current-period cost run-rate cannot be determined from this snapshot. Analysts should strip out reserve movements before extrapolating recent EPS levels.

Regulatory Exposure Could Reverse Recent Gains

Recent disclosures note ongoing DOJ investigations into Medicare Advantage coding practices, a risk that a beat-and-raise quarter such as the reported 2026Q3 EPS of $4.56 does not mitigate and that could pressure forward earnings.

If the DOJ inquiry results in material penalties or required changes to risk-adjustment coding, the Medicare Advantage franchise and Optum Health economics could be materially affected. The strong Q3 result may reflect cost discipline, but it does not resolve the underlying legal exposure. Resolution timing and financial impact remain unquantified in the supplied data and warrant further investigation.

Scale Advantages Versus Peer Margin Compression

Based on peer context data, UNH's operating margin of the broader group sits well above CNC's negative 3.9% and HUM's 1.1%, though the supplied peer set does not isolate UNH's own operating margin, limiting direct comparison.

Peer data indicate the managed care group is under broad margin strain, with several competitors reporting thin or negative operating margins. UNH's scale and vertically integrated Optum structure may support a more resilient expense base, but the supplied figures do not allow a direct measurement of its expense ratio efficiency. Investors should treat relative-scale conclusions as provisional until segment-level expense data are reviewed.

UNH — Frequently Asked Questions

Quick answers to the most common questions about buying UNH stock.

What was UnitedHealth Group Incorporated's (UNH) revenue in 2025?

For fiscal year 2025, UnitedHealth Group Incorporated (UNH) reported total revenue of $447.57B. This represents a 4342.9% increase compared to $10.07B in 1996.

Is UnitedHealth Group Incorporated (UNH) profitable?

UnitedHealth Group Incorporated (UNH) is profitable, generating $12.06B in net income for the fiscal year ending 2025 with a net profit margin of 2.7%.

What is UnitedHealth Group Incorporated's operating profit margin?

UnitedHealth Group Incorporated (UNH) reported an operating income of $18.96B, resulting in an operating profit margin of 4.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is UnitedHealth Group Incorporated's gross profit and gross margin?

UnitedHealth Group Incorporated (UNH) generated $82.92B in gross profit for the year, representing a gross profit margin of 18.5%. This demonstrates the company's core pricing power and production efficiency.